AMH and polycystic ovary syndrome: Overall, ourfindings contribute to the complex understanding of AMH as a prognostic biomarker inreproductive outcomes for women undergoing AI, particularly those affected by PCOS.Further longitudinal studies are warranted to elucidate the nuanced relationshipsbetween AMH levels, ovarian reserve, and reproductive outcomes across diversepopulations.